What Is Measles Virus?
The measles virus — also called rubeola — is one of the most contagious infectious diseases known to medical science, and in 2026, it has staged a dramatic and alarming comeback across the United States. Caused by a paramyxovirus transmitted through airborne respiratory droplets, measles spreads easily when an infected person coughs, sneezes, or even breathes in a shared space. The virus can linger in the air for up to two hours after an infected person has left the room, making it extraordinarily difficult to contain once it enters an under-vaccinated community. What makes the 2026 measles situation in America especially disturbing is that the country achieved measles elimination status in the year 2000 — a monumental public health triumph that took decades of sustained vaccination efforts to accomplish. That hard-won achievement is now under severe threat for the first time in a generation.
As of late February 2026, the United States has confirmed over 1,136 measles cases in just the first two months of the year alone — a number that is already nearing half of all cases recorded in all of 2025. The outbreak epicenter has shifted to South Carolina, where a single, relentless outbreak has produced nearly 1,000 cases since it first ignited in the fall of 2025. Public health experts, epidemiologists, and pediatricians across the country are sounding the alarm: declining MMR (measles, mumps, and rubella) vaccination rates, growing vaccine hesitancy, and shifting federal attitudes toward immunization mandates have created the perfect conditions for measles to re-establish itself as an endemic disease in America. Understanding the depth of this crisis requires looking closely at both the facts and the hard numbers behind the 2026 measles resurgence in the US.
Interesting Measles Virus Facts in the US 2026
Before diving into the statistics, it helps to understand the fundamental facts that make measles such a unique and dangerous pathogen — especially in the current American landscape.
| Fact | Detail |
|---|---|
| Contagion rate (R₀) | 12–18, meaning one infected person can spread measles to 12–18 unvaccinated individuals |
| Airborne survival | The measles virus can survive in the air and on surfaces for up to 2 hours after an infected person leaves a room |
| Vaccine introduction year | The measles vaccine was first introduced in the United States in 1963 |
| US elimination year | Measles was officially declared eliminated in the US in the year 2000 |
| MMR vaccine efficacy (1 dose) | 93% protection against measles after a single MMR dose |
| MMR vaccine efficacy (2 doses) | 97% protection against measles after two MMR doses — protection that typically lasts a lifetime |
| Herd immunity threshold | At least 95% of the population must be immune (vaccinated or previously infected) to prevent community spread |
| Pre-vaccine annual infections | Before 1963, an estimated 3–4 million Americans were infected with measles every year |
| Pre-vaccine annual deaths | Between 400–500 people died annually from measles in the US before the vaccine era |
| Pre-vaccine hospitalizations | Approximately 48,000 people were hospitalized each year from measles before vaccines |
| Vaccine-prevented deaths (1994–2023) | The measles vaccine prevented an estimated 85,000 deaths in the US between 1994 and 2023 |
| SSPE risk (pre-elimination era) | Before measles elimination, 7–11 out of every 100,000 people infected were at risk for subacute sclerosing panencephalitis (SSPE), a fatal brain disease |
| Encephalitis risk | About 1 in every 1,000 children with measles develops brain swelling that can result in permanent brain damage |
| Fatality risk in children | Up to 3 out of every 1,000 children infected with measles will die from complications |
| Immune amnesia | Measles infection suppresses the immune system and can erase previously acquired immunity to other diseases for months or even years after recovery |
| Childhood vaccination decline | US kindergarten MMR vaccination coverage dropped from 95.2% in the 2019–2020 school year to 92.7% in the 2023–2024 school year |
| Unvaccinated kindergartners at risk | The decline in coverage left approximately 280,000 kindergartners unprotected during the 2023–2024 school year |
Source: Centers for Disease Control and Prevention (CDC); National Center for Immunization and Respiratory Diseases
The facts above paint a picture of a disease that is biologically ruthless and epidemiologically unforgiving. The measles virus has one of the highest reproductive numbers of any known infectious disease — significantly higher than COVID-19, influenza, or even chickenpox. When you combine that extraordinary contagiousness with the documented drop in MMR vaccination rates among American kindergartners, the math becomes brutally straightforward. The 95% herd immunity threshold is not optional — it is the precise floor below which measles outbreaks become essentially inevitable. The US is currently operating at 92.7% kindergarten vaccination coverage, a gap that, while seemingly small in percentage terms, translates to hundreds of thousands of vulnerable children and adults in communities across the country. The historical facts underscore just how catastrophic measles was before vaccines transformed the landscape: 48,000 annual hospitalizations and up to 500 deaths per year were considered normal before 1963. Letting vaccination rates slip is not a neutral decision — it is a decision to court a return to those numbers.
Measles Virus Cases in the US 2026 — Year-to-Date Statistics
The most current confirmed data from the CDC captures just how rapidly measles has been spreading across the United States in 2026.
| Metric | 2026 Data (as of February 26, 2026) |
|---|---|
| Total confirmed measles cases | 1,136 |
| Number of US jurisdictions reporting cases | 28 (including states and New York City) |
| Cases among US residents | 1,130 |
| Cases among international visitors | 6 |
| New outbreaks reported in 2026 | 10 |
| Outbreak-associated cases | 1,023 (90% of total) |
| Cases linked to outbreaks starting in 2025 continuing into 2026 | 871 |
| Cases from outbreaks starting in 2026 | 152 |
| Unvaccinated or unknown vaccination status | 94% of confirmed cases |
| Cases in children 5 years and under | 25% of confirmed cases |
| Cases in individuals 19 years and under | 84–85% of confirmed cases |
| Hospitalization rate in 2026 | 3–4% of confirmed cases |
| Measles deaths confirmed in 2026 | 0 confirmed deaths (as of late February 2026) |
| Rate comparison to same point in 2025 | 4 times higher than the same point in 2025 |
| Rate comparison to same point in 2024 | 25 times higher than the same point in 2024 |
Source: Centers for Disease Control and Prevention (CDC), Measles Cases and Outbreaks — updated February 27, 2026
What these numbers reveal is nothing short of extraordinary in the context of modern American public health. In just the first 57 days of 2026, the US has confirmed 1,136 measles cases — more than four times the case count at the same point in 2025, which itself was already the worst year for measles since 1991. The 90% outbreak-association rate tells us that this is not random, sporadic importation of measles from abroad. This is sustained, community-level transmission happening inside the United States — precisely the kind of transmission pattern that puts the nation’s measles elimination status in jeopardy. The near-total concentration of cases among the unvaccinated or those with unknown vaccination status (94%) reinforces the core message that MMR vaccination remains the single most effective tool available to stop this outbreak. The hospitalization rate of 3–4% in 2026, while lower than the 11% recorded in 2025, still represents dozens of Americans requiring hospital care from a fully vaccine-preventable disease.
Measles Virus Outbreaks by State in the US 2026
Among all the states currently reporting cases, South Carolina has emerged as the undisputed epicenter of the 2026 measles crisis in the United States.
| State / Jurisdiction | Confirmed Cases in 2026 (as of late February 2026) |
|---|---|
| South Carolina | 632+ (CDC-confirmed); 985 total since fall 2025 outbreak began) |
| Utah | 117 |
| Florida | 64–92 (varies by tracking source) |
| Arizona | 36–49 |
| Washington State | 24–26 |
| New Mexico | Reporting cases (part of broader outbreak network) |
| Texas | Reporting cases (continuation from 2025 outbreak) |
| Virginia | 10 |
| Idaho | 7 (2026 portion) |
| Other 18 jurisdictions | Reporting smaller case clusters |
Source: Centers for Disease Control and Prevention (CDC); state health department updates — February 2026
The South Carolina measles outbreak is in a category of its own. With 985 total cases since the outbreak first began in the fall of 2025, this is the largest single measles outbreak the United States has seen in a full generation. By late February 2026, the South Carolina Department of Public Health reported that 919 of those cases were in people who had not received the MMR vaccine — a devastating demonstration of how quickly measles moves through unvaccinated communities. The Utah and Arizona outbreaks, while smaller in absolute numbers, have similarly been concentrated in communities with lower-than-average MMR vaccination coverage, including schools and church communities where close contact accelerates transmission. Florida’s case count is complicated by incomplete state-level reporting, but multiple tracking sources confirm it as one of the most significantly affected states. The geographic spread — from the Southeast to the Mountain West to the Pacific Northwest — confirms that this is a truly national measles crisis in America in 2026, not a regional anomaly.
Measles Virus Historical Case Trends in the US 2026 — Year-by-Year Comparison
To fully appreciate the scale of the 2026 measles surge, it is essential to see how the current numbers compare against the historical record.
| Year | Total Confirmed US Measles Cases | Notable Context |
|---|---|---|
| 2019 | 1,274–1,282 | Largest US outbreak in 27 years at the time; concentrated in New York |
| 2020 | 13 | Dramatically reduced due to COVID-19 lockdowns limiting travel and social contact |
| 2021 | 49 | Low case count; pandemic-era travel restrictions remained partially in effect |
| 2022 | 121 | Cases rose post-pandemic; major Ohio outbreak |
| 2023 | 58–59 | Relatively low year |
| 2024 | 285 | Cases more than quadrupled from 2023; 16 outbreaks |
| 2025 | 2,281 | Worst year since 1991; 50 outbreaks; 3 confirmed deaths |
| 2026 (YTD through Feb 26) | 1,136 | Already on pace to surpass 2025 full-year total by spring |
Source: Centers for Disease Control and Prevention (CDC), Measles Cases and Outbreaks — historical data
The historical trajectory tells a story that public health officials have been warning about for years. From the relative calm of 2020–2023 — when the pandemic paradoxically suppressed measles transmission by reducing travel and social mixing — the United States has experienced a dramatic and accelerating resurgence. The leap from 285 cases in 2024 to 2,281 cases in 2025 represents an 800% increase in a single year, the sharpest annual jump in confirmed US measles cases in modern public health history. And 2026 is beginning at a pace that makes even 2025 look modest by comparison: reaching 1,136 cases by February 26 puts the current year on trajectory to potentially exceed 7,000+ total cases if current weekly rates continue unchecked. That would place 2026 in territory not seen since the pre-vaccine era. The 2019 outbreak — which was then considered unprecedented — has already been surpassed in scale by the ongoing crisis. The collapse from 1,274 cases in 2019 to just 13 in 2020 showed that measles can be suppressed with the right conditions. The explosion since 2024 shows what happens when those conditions — chiefly, high MMR vaccination coverage — begin to erode.
Measles Virus Patient Demographics in the US 2026
Understanding who is getting infected matters enormously for how public health officials target their vaccination outreach and outbreak response.
| Demographic Category | 2026 Data | 2025 Comparison Data |
|---|---|---|
| Children under 5 years old | 25–27% of cases | 26–31% of cases |
| Children and young adults ages 5–19 | 57–59% of cases | 38–41% of cases |
| Total cases in individuals 19 and under | 84–85% | Roughly 67–70% |
| Adults 20 years and older | 11% in 2026 | 30% in 2025 |
| Unvaccinated or unknown vaccination status | 93–94% of all cases | 93–96% of all cases |
| Received 1 MMR dose | Approximately 1% | Approximately 1% |
| Received 2 MMR doses | Approximately 2–3% | Approximately 2% |
| Median patient age in 2025 | 9 years | — |
| Hospitalization rate in children under 5 | 23% in 2025; declining in 2026 | 23% (early 2025 data) |
| Hospitalization rate in ages 5–19 | 9% in 2025 | — |
| Hospitalization rate in adults 20+ | 8% in 2025 | — |
Source: CDC Morbidity and Mortality Weekly Report; CDC Measles Cases and Outbreaks, 2025–2026
The demographic picture of the 2026 measles epidemic is both clear and deeply concerning. The overwhelming majority — 84–85% — of all confirmed cases are in children and young adults age 19 and younger, a shift that reflects where the gaps in MMR vaccination coverage are most concentrated: in school-age communities. The dramatic drop in adult cases — from 30% of the total in 2025 down to just 11% in 2026 — likely reflects that older adults either carry immunity from prior infection or from vaccines administered decades ago when coverage was higher. The persistent concentration of cases among the unvaccinated or those with unknown vaccine status (94%) leaves absolutely no ambiguity about the primary driver of this outbreak. The two-dose MMR vaccine, which provides 97% protection, is performing exactly as designed — but only for those who actually received it. The age data also has urgent clinical implications: children under 5 experience the highest hospitalization rates (23% in early 2025 data), making this age group particularly vulnerable to severe disease, pneumonia, encephalitis, and the rare but fatal subacute sclerosing panencephalitis (SSPE).
Measles Virus Vaccination Coverage Statistics in the US 2026
At the heart of the 2026 measles crisis in the United States is a measurable, documented decline in MMR vaccination coverage that has left growing pockets of the American population susceptible to infection.
| Vaccination Metric | Data |
|---|---|
| Kindergarten MMR coverage — 2019–2020 school year | 95.2% |
| Kindergarten MMR coverage — 2021–2022 school year | ~93% |
| Kindergarten MMR coverage — 2023–2024 school year | 92.7% |
| Herd immunity threshold required | ≥95% of population |
| States maintaining ≥95% kindergarten MMR coverage | Only 10 states + Washington, DC |
| Estimated unprotected kindergartners in 2023–2024 | Approximately 280,000 |
| Adolescents ages 13–17 with 2+ MMR doses (2019) | 91.9% |
| MMR efficacy after 1 dose | 93% |
| MMR efficacy after 2 doses | 97% |
| Protection duration after 2 doses | Typically lifelong |
| Vaccinated breakthrough case risk | Approximately 3% of vaccinated individuals can still contract measles |
Source: Centers for Disease Control and Prevention (CDC), VaxView Program; National Center for Health Statistics
The vaccination coverage data exposes the structural vulnerability that has allowed measles to gain its current foothold in the United States in 2026. The national kindergarten MMR vaccination rate has slipped from 95.2% in 2019–2020 to 92.7% in 2023–2024 — a drop of 2.5 percentage points that may sound modest but carries enormous epidemiological consequences. The 95% threshold is not an arbitrary target; it is the precise level of community immunity required to interrupt measles transmission given the virus’s extreme contagiousness. Falling below that threshold in a population of 4+ million kindergartners means that approximately 280,000 young children entered school without protection, and in communities where vaccination rates are even lower — some dipping into the 70–80% range — measles can spread with near-unchecked velocity. The fact that only 10 states and Washington, DC are currently maintaining the ≥95% coverage threshold means the vast majority of the country is operating below the population immunity level needed for reliable protection. Without urgent, sustained efforts to close these vaccination gaps, experts warn that measles could re-establish continuous domestic transmission and the United States could permanently lose its elimination status, a status that was first declared in 2000 and that took decades of public health work to achieve.
Measles Virus Outbreak Counts and Trends in the US 2026
The frequency and scale of measles outbreaks in the United States has followed a steep upward trajectory that tracks directly with the decline in vaccination coverage.
| Year | Number of Outbreaks | % of Cases that are Outbreak-Associated |
|---|---|---|
| 2019 | Major outbreak clusters | High percentage |
| 2020 | Minimal | Near zero (pandemic effect) |
| 2021 | 4 | Moderate |
| 2022 | 15 | High |
| 2023 | 4–7 | 49% |
| 2024 | 16 | 69% |
| 2025 | 50 | 90% |
| 2026 (YTD through Feb 26) | 10 new outbreaks | 90% (1,023 of 1,136 cases) |
Source: Centers for Disease Control and Prevention (CDC), Measles Cases and Outbreaks — 2021–2026
The outbreak data is as striking as the raw case counts, and in some ways more telling. The jump from 16 outbreaks in 2024 to 50 outbreaks in 2025 represents a more than threefold increase in a single year, and already in the first two months of 2026, 10 new outbreaks have been identified — a pace that would put the full-year 2026 total far above even 2025’s record. Equally alarming is the outbreak-association rate: in 2023, only about half of measles cases were linked to defined outbreaks, suggesting many were still individual imported cases. By 2025 and 2026, 90% of all cases are outbreak-associated, which is the epidemiological fingerprint of sustained, community-level measles transmission. This is no longer a situation of isolated travelers bringing measles back from abroad and infecting a handful of contacts. This is measles spreading through American schools, churches, and neighborhoods with the kind of efficiency that only occurs when community immunity has genuinely broken down. The CDC’s definition of a measles outbreak requires just three or more related cases — meaning the 10 outbreaks already documented in early 2026 each represent a chain of transmission that required multiple unvaccinated individuals in proximity to one another.
Measles Virus Complications and Mortality Data in the US 2026
Measles is far more than a rash and a fever. The virus carries serious and sometimes permanent health consequences, particularly for young children and unvaccinated individuals.
| Complication / Outcome | Data |
|---|---|
| Confirmed measles deaths in 2026 (as of Feb 26) | 0 confirmed deaths |
| Confirmed measles deaths in 2025 | 3 confirmed deaths (2 children, 1 adult — all unvaccinated) |
| Hospitalization rate 2026 | 3–4% of confirmed cases |
| Hospitalization rate 2025 | 11% of confirmed cases |
| Hospitalization rate for children under 5 (2025) | 23% |
| Risk of encephalitis (brain swelling) | ~1 in 1,000 children infected |
| Risk of death in children from measles | Up to 3 in every 1,000 children infected |
| Risk of pneumonia | 1 in 20 unvaccinated people who get measles |
| Subacute Sclerosing Panencephalitis (SSPE) | Fatal brain disease; can develop 7–10 years after measles infection |
| Immune amnesia duration | Measles can suppress immune memory for months to years after recovery |
| Estimated annual pre-vaccine deaths in the US | 400–500 deaths per year (before 1963) |
| Estimated annual pre-vaccine hospitalizations | ~48,000 per year (before 1963) |
Source: Centers for Disease Control and Prevention (CDC); CDC Morbidity and Mortality Weekly Report; National Center for Immunization and Respiratory Diseases
The complication and mortality data for measles in the United States in 2026 carries a complicated message. On one hand, the current 3–4% hospitalization rate represents a significant improvement over 2025’s 11% rate, and zero confirmed deaths through late February 2026 is genuinely good news compared to the 3 deaths recorded in 2025. However, these numbers must be read in context: the current case count is only two months into the year, the trajectory is steeply upward, and the historical complication rates for measles remain unchanged by the fact that more cases are currently occurring in communities with access to hospital care. The 1-in-1,000 encephalitis risk and the up to 3-in-1,000 death risk for children are not statistics from a different era — they reflect the biological reality of this virus today. The three individuals who died from measles in 2025 were all unvaccinated, reinforcing the most critical point in all of this data: virtually every hospitalization, every death, and every case of measles-induced immune amnesia occurring in America in 2026 is medically preventable with a freely available, proven, and safe two-dose MMR vaccine.
Measles Virus Elimination Status Risk for the United States in 2026
Perhaps the most consequential long-term statistic in the entire 2026 measles story is the genuine and growing threat that the United States will lose its measles elimination status — a public health achievement that took generations to build.
| Elimination Status Metric | Detail |
|---|---|
| Year US achieved measles elimination | 2000 |
| Definition of elimination | No continuous endemic measles transmission for ≥12 months in the presence of a well-functioning surveillance system |
| PAHO Americas-wide elimination declared | 2016 |
| Americas-wide elimination status (as of Nov 2025) | Lost — PAHO declared the Americas lost elimination status in November 2025 |
| Canada’s elimination status | Lost in 2025 following prolonged domestic transmission |
| US individual elimination status (as of early 2026) | Under active CDC review; widely considered to be at imminent risk |
| PAHO review of US elimination status | Scheduled for April 2026 |
| Transmission chain trigger for loss of status | Continuous domestic chain of transmission for more than 12 months |
| Expert assessment | Multiple public health experts state the US has effectively “already lost” elimination status |
Source: Centers for Disease Control and Prevention (CDC); Pan American Health Organization (PAHO); Association of State and Territorial Health Officials (ASTHO)
The elimination status data may be the single most sobering set of facts in the entire measles story in America in 2026. The US earned measles elimination in 2000, a milestone that reflected decades of national commitment to childhood vaccination. In November 2025, the Pan American Health Organization formally declared that the entire Americas region — including the United States and Canada — had lost measles elimination status due to sustained endemic transmission. Canada officially lost its individual elimination status in 2025. For the United States, the CDC was still conducting analysis in early 2026 to determine whether the various ongoing outbreaks constitute a continuous domestic chain of transmission — the technical trigger for formally losing status. But leading epidemiologists have stated openly that in their professional assessment, the US has effectively already lost its measles elimination status, even before a formal PAHO declaration. The April 2026 review will be a defining moment in American public health history. Regaining elimination status, once lost, requires demonstrating 12 consecutive months without endemic transmission — a bar that, given the current trajectory of 1,136 cases and 10 outbreaks in just the first two months of the year, will be extraordinarily difficult to clear without a dramatic and immediate national pivot back toward robust MMR vaccination coverage.
Disclaimer: The data reports published on The Global Files are sourced from publicly available materials considered reliable. While efforts are made to ensure accuracy, no guarantees are provided regarding completeness or reliability. The Global Files is not liable for any errors, omissions, or damages resulting from the use of these reports.

